Category Archives: Business and Investments

Latest From Business and Investments

Tick Size Pilot Program: A Few Pennies Make a Big Difference


Earlier this week, the Securities and Exchange Commission (SEC) approved a tick size pilot program that will begin next year. We issued this statement, praising the SEC for finalizing this program, which could improve liquidity and enhance capital formation for emerging biotech companies. Under current SEC rules, all securities on the public market are priced in $0.01 increments known as “tick sizes.” The switch to the standard tick size of a penny was enacted in 2000 Read More >

Business and Investments, Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , ,

FOX Business: BIO CEO Jim Greenwood Discusses State of the Industry


BIO President and CEO Jim Greenwood recently appeared on Fox Business Risk & Reward with Deirdre Bolton to discuss the current state of the industry. Greenwood quickly debunked the “bubble” rumor by explaining the index continues to move up year over year and it is driven by strong science that results in strong returns and that increasing sophistication among investors allows them to more accurately assess company valuations than in the past. Further, Greenwood addressed Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , ,

2015: A Promising Year for Biotech Jobs


If you’re in the biotech sector and are looking for a new career, you’re in luck: according to a recent survey by BioSpace, 70% of respondents believe new jobs will be on the horizon this year. The majority of respondents say that small firms will lead the hiring rush. The poll was split over where most hiring would occur, with 39% believing it would go to research and development jobs, and 39% believing it would Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Innovation Files: CSBI Tax Proposals Attempt to Bridge “Valley of Death”


Over at the Innovation Files, Joe Kennedy has posted an excellent summary of a set of tax reform proposals developed by the Coalition of Small Business Innovators (CSBI), of which BIO is a member. The proposals would increase investment and employment at small, research intensive companiesby allowing investors to take advantage of passive losses and research credits generated by the company. They would also allow companies to carry net operating losses forward to future years Read More >

Business and Investments, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO’s Dave Thomas Talks VC Funding with Daniel Levine


Last week, BIO Industry Analysis’s Dave Thomas spoke with Daniel Levine for his weekly podcast, The Bio Report. Dave discussed BIO‘s Venture Funding of Therapeutic Innovation Report, of which he is the lead author. The report analyzes data from four venture capital databases – Thomson Reuters, BioCentury, Elsevier, and Evaluate Pharm – to investigate investor trends, examine investment in specific therapeutic areas and indications, and identify disease areas that might be struggling for early-stage venture Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , ,